Literature DB >> 1555351

Epithelial cell lines that induce bone formation in vivo produce alkaline phosphatase-enriched matrix vesicles in culture.

B D Boyan1, L D Swain, Z Schwartz, V Ramirez, D L Carnes.   

Abstract

Hypertrophic chondrocytes and osteoblasts produce alkaline phosphatase (ALPase)-enriched matrix vesicles in vivo and in vitro and, along with certain epithelial cell lines and osteoblast precursors, induce bone when implanted in mesenchymal tissues. This study examined whether ALPase-enriched matrix vesicle production in vitro was a general property of cells that induce bone in vivo. Epithelial cell lines FL, WISH, and OK 16; connective tissue cell lines HEPM 1 and HEPM 2; neonatal rat muscle cells; rat costochondral chondrocytes; and human fibroblasts were implanted intramuscularly into nude mice. The FL and WISH cells produced tumors and induced large islands of bone with focal areas of cartilage immediately adjacent to the tumors. The chondrocytes formed cartilage nodules but did not induce bone, indicating that the ability of the cells to form a solid mass was not an a priori requirement for bone formation. No other cell type produced tumors or nodules or induced bone formation, although connective tissue cells have been shown to induce chondrogenesis in vitro and osteogenesis in vivo. Only matrix vesicles from normal chondrocytes, FL, WISH, and OK16 cultures exhibited enriched ALPase-specific activity. Matrix vesicles from FL and WISH cultures exhibited ALPase specific activities similar to those isolated from osteoblast or chondrocyte cultures. These data suggest that the ability to produce ALPase-enriched matrix vesicles in culture may be associated with the ability of cells to induce bone or cartilage in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555351

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Epigenetic regulation of osteogenesis: human embryonic palatal mesenchymal cells.

Authors:  Andre Barkhordarian; Jay Sison; Riana Cayabyab; Nicole Mahanian; Francesco Chiappelli
Journal:  Bioinformation       Date:  2011-01-06

2.  Treatment of resting zone chondrocytes with bone morphogenetic protein-2 induces maturation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.

Authors:  Z Schwartz; V L Sylvia; Y Liu; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

3.  A potential role for tetranectin in mineralization during osteogenesis.

Authors:  U M Wewer; K Ibaraki; P Schjørring; M E Durkin; M F Young; R Albrechtsen
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.